A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease
Autore
Krüger, R.; Sharma, M.; Riess, O.; Gasser, T.; Van Broeckhoven, C.; Theuns, J.; Aasly, J.; Annesi, G.; Bentivoglio, A. R.; Brice, A.; Djarmati, A.; Elbaz, A.; Farrer, M.; Ferrarese, C.; Gibson, J. M.; Hadjigeorgiou, G. M.; Hattori, N.; Ioannidis, J. P. A.; Jasinska-Myga, B.; Klein, C.; Lambert, J. C.; Lesage, S.; Lin, J. J.; Lynch, T.; Mellick, G. D.; de Nigris, F.; Opala, G.; Prigione, A.; Quattrone, A.; Ross, O. A.; Satake, W.; Silburn, P. A.; Tan, E. K.; Toda, T.; Tomiyama, H.; Wirdefeldt, K.; Wszolek, Z.; Xiromerisiou, G.; Maraganore, D. M.Data
2011Soggetto
Abstract
High-profile studies have provided conflicting results regarding the involvement of the Omi/HtrA2 gene in Parkinson's disease (PD) susceptibility. Therefore, we performed a large-scale analysis of the association of common Omi/HtrA2 variants in the Genetic Epidemiology of Parkinson's disease (GEO-PD) consortium.GEO-PD sites provided clinical and genetic data including affection status, gender, ethnicity, age at study, age at examination (all subjects); age at onset and family history of PD (patients). Genotyping was performed for the five most informative SNPs spanning the Omi/HtrA2 gene in approximately 2-3. kb intervals (rs10779958, rs2231250, rs72470544, rs1183739, rs2241028). Fixed as well as random effect models were used to provide summary risk estimates of Omi/HtrA2 variants.The 20 GEO-PD sites provided data for 6378 cases and 8880 controls. No overall significant associations for the five Omi/HtrA2 SNPs and PD were observed using either fixed effect or random effect models. The summary odds ratios ranged between 0.98 and 1.08 and the estimates of between-study heterogeneity were not large (non-significant Q statistics for all 5 SNPs; I2 estimates 0-28%). Trends for association were seen for participants of Scandinavian descent for rs2241028 (OR 1.41, p=0.04) and for rs1183739 for age at examination (cut-off 65 years; OR 1.17, p=0.02), but these would not be significant after adjusting for multiple comparisons and their Bayes factors were only modest.This largest association study performed to define the role of any gene in the pathogenesis of Parkinson's disease revealed no overall strong association of Omi/HtrA2 variants with PD in populations worldwide. © 2009 Elsevier Inc.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015
Barber R.M., Fullman N., Sorensen R.J.D., Bollyky T., McKee M., Nolte E., Abajobir A.A., Abate K.H., Abbafati C., Abbas K.M., Abd-Allah F., Abdulle A.M., Abdurahman A.A., Abera S.F., Abraham B., Abreha G.F., Adane K., Adelekan A.L., Adetifa I.M.O., Afshin A., Agarwal A., Agarwal S.K., Agarwal S., Agrawal A., Ahmad Kiadaliri A., Ahmadi A., Ahmed K.Y., Ahmed M.B., Akinyemi R.O., Akinyemiju T.F., Akseer N., Al-Aly Z., Alam K., Alam N., Alam S.S., Alemu Z.A., Alene K.A., Alexander L., Ali R., Ali S.D., Alizadeh-Navaei R., Alkerwi A., Alla F., Allebeck P., Allen C., Al-Raddadi R., Alsharif U., Altirkawi K.A., Alvarez Martin E., Alvis-Guzman N., Amare A.T., Amini E., Ammar W., Amo-Adjei J., Amoako Y.A., Anderson B.O., Androudi S., Ansari H., Ansha M.G., Antonio C.A.T., Ärnlöv J., Artaman A., Asayesh H., Assadi R., Astatkie A., Atey T.M., Atique S., Atnafu N.T., Atre S.R., Avila-Burgos L., Avokpaho E.F.G.A., Ayala Quintanilla B.P., Awasthi A., Ayele N.N., Azzopardi P., Ba Saleem H.O., Bärnighausen T., Bacha U., Badawi A., Banerjee A., Barac A., Barboza M.A., Barker-Collo S.L., Barrero L.H., Basu S., Baune B.T., Baye K., Bayou Y.T., Bazargan-Hejazi S., Bedi N., Beghi E., Béjot Y., Bello A.K., Bennett D.A., Bensenor I.M., Berhane A., Bernabé E., Bernal O.A., Beyene A.S., Beyene T.J., Bhutta Z.A., Biadgilign S., Bikbov B., Birlik S.M., Birungi C., Biryukov S., Bisanzio D., Bizuayehu H.M., Bose D., Brainin M., Brauer M., Brazinova A., Breitborde N.J.K., Brenner H., Butt Z.A., Cárdenas R., Cahuana-Hurtado L., Campos-Nonato I.R., Car J., Carrero J.J., Casey D., Caso V., Castañeda-Orjuela C.A., Castillo Rivas J., Catalá-López F., Cecilio P., Cercy K., Charlson F.J., Chen A.Z., Chew A., Chibalabala M., Chibueze C.E., Chisumpa V.H., Chitheer A.A., Chowdhury R., Christensen H., Christopher D.J., Ciobanu L.G., Cirillo M., Coggeshall M.S., Cooper L.T., Cortinovis M., Crump J.A., Dalal K., Danawi H., Dandona L., Dandona R., Dargan P.I., Das Neves J., Davey G., Davitoiu D.V., Davletov K., De Leo D., Del Gobbo L.C., Del Pozo-Cruz B., Dellavalle R.P., Deribe K., Deribew A., Des Jarlais D.C., Dey S., Dharmaratne S.D., Dicker D., Ding E.L., Dokova K., Dorsey E.R., Doyle K.E., Dubey M., Ehrenkranz R., Ellingsen C.L., Elyazar I., Enayati A., Ermakov S.P., Eshrati B., Esteghamati A., Estep K., Fürst T., Faghmous I.D.A., Fanuel F.B.B., Faraon E.J.A., Farid T.A., Farinha C.S.E.S., Faro A., Farvid M.S., Farzadfar F., Feigin V.L., Feigl A.B., Fereshtehnejad S.-M., Fernandes J.G., Fernandes J.C., Feyissa T.R., Fischer F., Fitzmaurice C., Fleming T.D., Foigt N., Foreman K.J., Forouzanfar M.H., Franklin R.C., Frostad J., Ghiwot T.T., Gakidou E., Gambashidze K., Gamkrelidze A., Gao W., Garcia-Basteiro A.L., Gebre T., Gebremedhin A.T., Gebremichael M.W., Gebru A.A., Gelaye A.A., Geleijnse J.M., Genova-Maleras R., Gibney K.B., Giref A.Z., Gishu M.D., Giussani G., Godwin W.W., Gold A., Goldberg E.M., Gona P.N., Goodridge A., Gopalani S.V., Goto A., Graetz N., Greaves F., Griswold M., Guban P.I., Gugnani H.C., Gupta P.C., Gupta R., Gupta R., Gupta T., Gupta V., Habtewold T.D., Hafezi-Nejad N., Haile D., Hailu A.D., Hailu G.B., Hakuzimana A., Hamadeh R.R., Hambisa M.T., Hamidi S., Hammami M., Hankey G.J., Hao Y., Harb H.L., Hareri H.A., Haro J.M., Hassanvand M.S., Havmoeller R., Hay R.J., Hay S.I., Hendrie D., Heredia-Pi I.B., Hoek H.W., Horino M., Horita N., Hosgood H.D., Htet A.S., Hu G., Huang H., Huang J.J., Huntley B.M., Huynh C., Iburg K.M., Ileanu B.V., Innos K., Irenso A.A., Jahanmehr N., Jakovljevic M.B., James P., James S.L., Javanbakht M., Jayaraman S.P., Jayatilleke A.U., Jeemon P., Jha V., John D., Johnson C., Johnson S.C., Jonas J.B., Juel K., Kabir Z., Kalkonde Y., Kamal R., Kan H., Karch A., Karema C.K., Karimi S.M., Kasaeian A., Kassebaum N.J., Kastor A., Katikireddi S.V., Kazanjan K., Keiyoro P.N., Kemmer L., Kemp A.H., Kengne A.P., Kerbo A.A., Kereselidze M., Kesavachandran C.N., Khader Y.S., Khalil I., Khan A.R., Khan E.A., Khan G., Khang Y.-H., Khoja A.T.A., Khonelidze I., Khubchandani J., Kibret G.D., Kim D., Kim P., Kim Y.J., Kimokoti R.W., Kinfu Y., Kissoon N., Kivipelto M., Kokubo Y., Kolk A., Kolte D., Kopec J.A., Kosen S., Koul P.A., Koyanagi A., Kravchenko M., Krishnaswami S., Krohn K.J., Kuate Defo B., Kucuk Bicer B., Kuipers E.J., Kulkarni V.S., Kumar G.A., Kumsa F.A., Kutz M., Kyu H.H., Lager A.C.J., Lal A., Lal D.K., Lalloo R., Lallukka T., Lan Q., Langan S.M., Lansingh V.C., Larson H.J., Larsson A., Laryea D.O., Latif A.A., Lawrynowicz A.E.B., Leasher J.L., Leigh J., Leinsalu M., Leshargie C.T., Leung J., Leung R., Levi M., Liang X., Lim S.S., Lind M., Linn S., Lipshultz S.E., Liu P., Liu Y., Lo L.-T., Logroscino G., Lopez A.D., Lorch S.A., Lotufo P.A., Lozano R., Lunevicius R., Lyons R.A., Macarayan E.R.K., Mackay M.T., Magdy Abd El Razek H., Magdy Abd El Razek M., Mahdavi M., Majeed A., Malekzadeh R., Malta D.C., Mantovani L.G., Manyazewal T., Mapoma C.C., Marcenes W., Marks G.B., Marquez N., Martinez-Raga J., Marzan M.B., Massano J., Mathur M.R., Maulik P.K., Mazidi M., McAlinden C., McGrath J.J., McNellan C., Meaney P.A., Mehari A., Mehndiratta M.M., Meier T., Mekonnen A.B., Meles K.G., Memish Z.A., Mengesha M.M., Mengiste D.T., Mengistie M.A., Menota B.G., Mensah G.A., Mereta S.T., Meretoja A., Meretoja T.J., Mezgebe H.B., Micha R., Millear A., Mills E.J., Minnig S., Mirarefin M., Mirrakhimov E.M., Mock C.N., Mohammad K.A., Mohammed S., Mohanty S.K., Mokdad A.H., Mola G.L.D., Molokhia M., Monasta L., Montico M., Moradi-Lakeh M., Moraga P., Morawska L., Mori R., Moses M., Mueller U.O., Murthy S., Musa K.I., Nachega J.B., Nagata C., Nagel G., Naghavi M., Naheed A., Naldi L., Nangia V., Nascimento B.R., Negoi I., Neupane S.P., Newton C.R., Ng M., Ngalesoni F.N., Ngunjiri J.W., Nguyen G., Ningrum D.N.A., Nolte S., Nomura M., Norheim O.F., Norrving B., Noubiap J.J.N., Obermeyer C.M., Ogbo F.A., Oh I.-H., Okoro A., Oladimeji O., Olagunju A.T., Olivares P.R., Olsen H.E., Olusanya B.O., Olusanya J.O., Opio J.N., Oren E., Ortiz A., Osborne R.H., Osman M., Owolabi M.O., Mahesh P.A., Pain A.W., Pakhale S., Palomares Castillo E., Pana A., Papachristou C., Parsaeian M., Patel T., Patton G.C., Paudel D., Paul V.K., Pearce N., Pereira D.M., Perez-Padilla R., Perez-Ruiz F., Perico N., Pesudovs K., Petzold M., Phillips M.R., Pigott D.M., Pillay J.D., Pinho C., Polinder S., Pond C.D., Prakash V., Purwar M., Qorbani M., Quistberg D.A., Radfar A., Rafay A., Rahimi K., Rahimi-Movaghar V., Rahman M., Rahman M.H.U., Rai R.K., Ram U., Rana S.M., Rankin Z., Rao P.V., Rao P.C., Rawaf S., Rego M.A.S., Reitsma M., Remuzzi G., Renzaho A.M.N.N., Resnikoff S., Rezaei S., Rezai M.S., Ribeiro A.L., Roba H.S., Rokni M.B., Ronfani L., Roshandel G., Roth G.A., Rothenbacher D., Roy N.K., Sachdev P.S., Sackey B.B., Saeedi M.Y., Safiri S., Sagar R., Sahraian M.A., Saleh M.M., Salomon J.A., Samy A.M., Sanabria J.R., Sanchez-Niño M.D., Sandar L., Santos I.S., Santos J.V., Santric Milicevic M.M., Sarmiento-Suarez R., Sartorius B., Satpathy M., Savic M., Sawhney M., Saylan M.I., Schöttker B., Schutte A.E., Schwebel D.C., Seedat S., Seid A.M., Seifu C.N., Sepanlou S.G., Serdar B., Servan-Mori E.E., Setegn T., Shackelford K.A., Shaheen A., Shahraz S., Shaikh M.A., Shakh-Nazarova M., Shamsipour M., Shariful Islam S.M., Sharma J., Sharma R., She J., Sheikhbahaei S., Shen J., Shi P., Shigematsu M., Shin M.-J., Shiri R., Shoman H., Shrime M.G., Sibamo E.L.S., Sigfusdottir I.D., Silva D.A.S., Silveira D.G.A., Sindi S., Singh A., Singh J.A., Singh O.P., Singh P.K., Singh V., Sinke A.H., Sinshaw A.E., Skirbekk V., Sliwa K., Smith A., Sobngwi E., Soneji S., Soriano J.B., Sousa T.C.M., Sposato L.A., Sreeramareddy C.T., Stathopoulou V., Steel N., Steiner C., Steinke S., Stokes M.A., Stranges S., Strong M., Stroumpoulis K., Sturua L., Sufiyan M.B., Suliankatchi R.A., Sun J., Sur P., Swaminathan S., Sykes B.L., Tabarés-Seisdedos R., Tabb K.M., Taffere G.R., Talongwa R.T., Tarajia M., Tavakkoli M., Taveira N., Teeple S., Tegegne T.K., Tehrani-Banihashemi A., Tekelab T., Tekle D.Y., Temam Shifa G., Terkawi A.S., Tesema A.G., Thakur J.S., Thomson A.J., Tillmann T., Tiruye T.Y., Tobe-Gai R., Tonelli M., Topor-Madry R., Tortajada M., Troeger C., Truelsen T., Tura A.K., Uchendu U.S., Ukwaja K.N., Undurraga E.A., Uneke C.J., Uthman O.A., Van Boven J.F.M., Van Dingenen R., Varughese S., Vasankari T., Venketasubramanian N., Violante F.S., Vladimirov S.K., Vlassov V.V., Vollset S.E., Vos T., Wagner J.A., Wakayo T., Waller S.G., Walson J.L., Wang H., Wang Y.-P., Watkins D.A., Weiderpass E., Weintraub R.G., Wen C.-P., Werdecker A., Wesana J., Westerman R., Whiteford H.A., Wilkinson J.D., Wiysonge C.S., Woldeyes B.G., Wolfe C.D.A., Won S., Workicho A., Workie S.B., Wubshet M., Xavier D., Xu G., Yadav A.K., Yaghoubi M., Yakob B., Yan L.L., Yano Y., Yaseri M., Yimam H.H., Yip P., Yonemoto N., Yoon S.-J., Younis M.Z., Yu C., Zaidi Z., El Sayed Zaki M., Zambrana-Torrelio C., Zapata T., Zenebe Z.M., Zodpey S., Zoeckler L., Zuhlke L.J., Murray C.J.L., GBD 2015 Healthcare Access and Quality Collaborators (2017)Background National levels of personal health-care access and quality can be approximated by measuring mortality rates from causes that should not be fatal in the presence of effective medical care (ie, amenable mortality). ... -
Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG)
Christodoulou C., Kalogera-Fountzila A., Karavasilis V., Kouvatseas G., Papandreou C.N., Samantas E., Varaki K., Papadopoulos G., Bobos M., Rallis G., Razis E., Goudopoulou A., Kalogeras K.T., Syrigos K.N., Fountzilas G. (2017)Small molecules, mainly tyrosine kinase inhibitors, are currently used in various malignancies. Lapatinib, a dual inhibitor of EGFR/HER2 tyrosine kinases, has demonstrated effectiveness in brain metastases from HER2-overexpressing ... -
Systemic Biomarkers of Collagen and Elastin Turnover Are Associated With Clinically Relevant Outcomes in COPD
Stolz D., Leeming D.J., Kristensen J.H.E., Karsdal M.A., Boersma W., Louis R., Milenkovic B., Kostikas K., Blasi F., Aerts J., Sand J.M.B., Wouters E.F.M., Rohde G., Prat C., Torres A., Welte T., Roth M., Papakonstantinou E., Tamm M. (2017)Background Extracellular matrix (ECM) remodeling of the lung tissue releases protein fragments into the blood, where they may be detected as serologic surrogate markers of disease activity in COPD. Our goal was to assess ...